90 related articles for article (PubMed ID: 10723769)
41. Combination of adsorption by porous CaCO3 microparticles and encapsulation by polyelectrolyte multilayer films for sustained drug delivery.
Wang C; He C; Tong Z; Liu X; Ren B; Zeng F
Int J Pharm; 2006 Feb; 308(1-2):160-7. PubMed ID: 16359836
[TBL] [Abstract][Full Text] [Related]
42. A study on maize proteins as a potential new tablet excipient.
Georget DM; Barker SA; Belton PS
Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
[TBL] [Abstract][Full Text] [Related]
43. Release of ibuprofen from beads for embolization: in vitro and in vivo studies.
Borovac T; Pelage JP; Kasselouri A; Prognon P; Guiffant G; Laurent A
J Control Release; 2006 Oct; 115(3):266-74. PubMed ID: 17045356
[TBL] [Abstract][Full Text] [Related]
44. Soft, chewable gelatin-based pharmaceutical oral formulations: a technical approach.
Dille MJ; Hattrem MN; Draget KI
Pharm Dev Technol; 2018 Jun; 23(5):504-511. PubMed ID: 28532266
[TBL] [Abstract][Full Text] [Related]
45. Influence of different sources on the processing and biopharmaceutical properties of high-dose ibuprofen formulations.
Romero AJ; Lukas G; Rhodes CT
Pharm Acta Helv; 1991; 66(2):34-43. PubMed ID: 1758891
[TBL] [Abstract][Full Text] [Related]
46. Rationale for ibuprofen co-administration with antacids: potential interaction mechanisms affecting drug absorption.
Parojcić J; Corrigan OI
Eur J Pharm Biopharm; 2008 Jun; 69(2):640-7. PubMed ID: 18280125
[TBL] [Abstract][Full Text] [Related]
47. Retarded dissolution of ibuprofen in gelatin microcapsule by cross-linking with glutaradehyde.
Yong CS; Li DX; Oh DH; Kim JA; Yoo BK; Woo JS; Rhee JD; Choi HG
Arch Pharm Res; 2006 Jun; 29(6):520-4. PubMed ID: 16833022
[TBL] [Abstract][Full Text] [Related]
48. Sustained Release Bilayer Tablet of Ibuprofen and Phenylephrine Hydrochloride: Preparation and Pharmacokinetics in Beagle Dogs.
Zhu C; Xu S; Han X; Wang W; He W; Yin L; Yang L; Qin C
AAPS PharmSciTech; 2019 Jan; 20(2):86. PubMed ID: 30673916
[TBL] [Abstract][Full Text] [Related]
49. Ibuprofen-loaded chitosan and chemically modified chitosans--release features from tablet and film forms.
Vieira AP; Badshah S; Airoldi C
Int J Biol Macromol; 2013 Jan; 52():107-15. PubMed ID: 23010457
[TBL] [Abstract][Full Text] [Related]
50. [Pharmaceutical technology of Cordaflex tablets].
Erdös S
Acta Pharm Hung; 1996 Jan; 66(1):41-5. PubMed ID: 8714364
[TBL] [Abstract][Full Text] [Related]
51. Preparation of agglomerated crystals for direct tabletting and microencapsulation by the spherical crystallization technique with a continuous system.
Niwa T; Takeuchi H; Hino T; Itoh A; Kawashima Y; Kiuchi K
Pharm Res; 1994 Apr; 11(4):478-84. PubMed ID: 8058601
[TBL] [Abstract][Full Text] [Related]
52. How suitable is the measurement of take-off forces for detection of sticking during direct compression of various ibuprofen tablet formulations?
Saniocki I; Sakmann A; Leopold CS
Pharm Dev Technol; 2013 Feb; 18(1):257-65. PubMed ID: 22931059
[TBL] [Abstract][Full Text] [Related]
53. One-step preparation of ibuprofen fast- and sustained-release formulation by electrospinning with improved efficacy and reduced side effect.
Che X; Xue J; Zhang J; Yang X; Wang L
Pharm Dev Technol; 2020 Jul; 25(6):659-665. PubMed ID: 32067550
[TBL] [Abstract][Full Text] [Related]
54. [Peroral long-acting drugs. VII. Tablets prepared of a granulated powder coated with fatty acids].
Chalabala M; Starha L; Muzik M
Cesk Farm; 1972 May; 21(4):153-5. PubMed ID: 5046010
[No Abstract] [Full Text] [Related]
55. A comparison in general practice of once and twice daily sustained-release ibuprofen and standard ibuprofen in the treatment of non-articular rheumatism.
Valle-Jones JC; Smith J; Rowley-Jones D
Br J Clin Pract; 1984 Oct; 38(10):353-8. PubMed ID: 6333885
[No Abstract] [Full Text] [Related]
56. Utilization of hydrophilic gums for the control of drug substance release from tablet formulations. II. Influence of tablet hardness and density on dissolution behavior.
Huber HE; Christenson GL
J Pharm Sci; 1968 Jan; 57(1):164-7. PubMed ID: 5652122
[No Abstract] [Full Text] [Related]
57. Controlled release Ibu-cryobarriers for the prevention of post-operative adhesions: In-vitro/in-vivo comparative study.
El-Salamouni NS; Gowayed MA; Labib GS
Int J Pharm; 2019 Jun; 565():70-82. PubMed ID: 31054878
[TBL] [Abstract][Full Text] [Related]
58. A freeze-dried injectable form of ibuprofen: development and optimisation using response surface methodology.
Kagkadis KA; Rekkas DM; Dallas PP; Choulis NH
PDA J Pharm Sci Technol; 1996; 50(5):317-23. PubMed ID: 8973118
[TBL] [Abstract][Full Text] [Related]
59. Is it necessary to take small blend samples to assess drug uniformity?
Bolton S; Sharma M; Cohen E; Nash R
Pharm Dev Technol; 1997 Aug; 2(3):297-9. PubMed ID: 9552458
[No Abstract] [Full Text] [Related]
60. Formulation and evaluation of ibuprofen injections.
Jain NK; Jahagirdar A
Pharmazie; 1989 Oct; 44(10):727-8. PubMed ID: 2616618
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
